Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

159 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Metabolic Syndrome in Cushing's Syndrome Patients.
Ferraù F, Korbonits M. Ferraù F, et al. Front Horm Res. 2018;49:85-103. doi: 10.1159/000486002. Epub 2018 Apr 5. Front Horm Res. 2018. PMID: 29894989 Review.
Health-related quality of life in patients with Cushing's syndrome.
Curtò L, Ferraù F, Trimarchi F. Curtò L, et al. Minerva Endocrinol. 2014 Mar;39(1):75-7. Minerva Endocrinol. 2014. PMID: 24513607 No abstract available.
Metabolic comorbidities in Cushing's syndrome.
Ferraù F, Korbonits M. Ferraù F, et al. Eur J Endocrinol. 2015 Oct;173(4):M133-57. doi: 10.1530/EJE-15-0354. Epub 2015 Jun 9. Eur J Endocrinol. 2015. PMID: 26060052 Review.
Pasireotide treatment reduces cardiometabolic risk in Cushing's disease patients: an Italian, multicenter study.
Albani A, Ferraù F, Ciresi A, Pivonello R, Scaroni C, Iacuaniello D, Zilio M, Guarnotta V, Alibrandi A, Messina E, Boscaro M, Giordano C, Colao A, Cannavo S. Albani A, et al. Endocrine. 2018 Jul;61(1):118-124. doi: 10.1007/s12020-018-1524-5. Epub 2018 Jan 30. Endocrine. 2018. PMID: 29383677
High bone marrow fat in patients with Cushing's syndrome and vertebral fractures.
Ferraù F, Giovinazzo S, Messina E, Tessitore A, Vinci S, Mazziotti G, Lania A, Granata F, Cannavò S. Ferraù F, et al. Endocrine. 2020 Jan;67(1):172-179. doi: 10.1007/s12020-019-02034-4. Epub 2019 Aug 2. Endocrine. 2020. PMID: 31376100
Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site : results of an Italian multicenter, randomized, phase II study.
Palmeri S, Lorusso V, Palmeri L, Vaglica M, Porta C, Nortilli R, Ferraú F, Comella G, Massidda B, Danova M; Carcinomas of Unknown Primary Italian Study Group. Palmeri S, et al. Cancer. 2006 Dec 15;107(12):2898-905. doi: 10.1002/cncr.22379. Cancer. 2006. PMID: 17109447 Clinical Trial.
Increased prevalence of acromegaly in a highly polluted area.
Cannavò S, Ferraù F, Ragonese M, Curtò L, Torre ML, Magistri M, Marchese A, Alibrandi A, Trimarchi F. Cannavò S, et al. Eur J Endocrinol. 2010 Oct;163(4):509-13. doi: 10.1530/EJE-10-0465. Epub 2010 Jul 9. Eur J Endocrinol. 2010. PMID: 20621957
Temozolomide-induced shrinkage of a pituitary carcinoma causing Cushing's disease--report of a case and literature review.
Curtò L, Torre ML, Ferraù F, Pitini V, Altavilla G, Granata F, Longo M, Hofland LJ, Trimarchi F, Cannavò S. Curtò L, et al. ScientificWorldJournal. 2010 Nov 4;10:2132-8. doi: 10.1100/tsw.2010.210. ScientificWorldJournal. 2010. PMID: 21057727 Free PMC article. Review.
Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL.
Cannavò S, Condurso R, Ragonese M, Ferraù F, Alibrandi A, Aricò I, Romanello G, Squadrito S, Trimarchi F, Silvestri R. Cannavò S, et al. Pituitary. 2011 Dec;14(4):328-34. doi: 10.1007/s11102-011-0298-z. Pituitary. 2011. PMID: 21328081
How to diagnose and manage Cushing's disease during pregnancy, when hypercortisolism is mild?
Ragonese M, Cotta OR, Ferraù F, Trimarchi F, Cannavò S. Ragonese M, et al. Gynecol Endocrinol. 2012 Aug;28(8):637-9. doi: 10.3109/09513590.2011.650762. Epub 2012 Feb 6. Gynecol Endocrinol. 2012. PMID: 22309603
159 results
Jump to page
Feedback